$PMD News

Last published 4mo ago

4mo agoPMDPsychemedics Releases 2026 Education Insights ReportGlobeNewswireDALLAS, June 30, 2026 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the pioneer and global leader in hair testing for drugs of abuse, today announced the release of its 2026 Education Insights Report, a comprehensive
6mo agoPMDPsychemedics Releases 2026 Workforce Insights ReportGlobeNewswireNew Data Highlights Shifting Drug Trends, Industry Risk Patterns, and the Growing Importance of Long-Window Testing DALLAS, April 30, 2026 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair
1y agoPMDPsychemedics Releases 2025 Workforce Insights ReportGlobeNewswireDALLAS, June 16, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair testing for drugs of abuse, today announced the release of its second annual Workforce Insights Report, providing a
1y agoPMDPsychemedics Named "Most Innovative Drug Testing Company of the Year"GlobeNewswireDALLAS, May 16, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world's leading provider of hair drug testing, is proud to announce it has been named "Most Innovative Drug Testing Company of the Year" by
1y agoPMDPsychemedics Launches Groundbreaking Quartile Reporting for Enhanced Drug Testing InsightsGlobeNewswireDALLAS, March 03, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair drug testing, is proud to announce the launch of its innovative Quartile Reporting feature. This industry-first enhancement
1y agoPMDPsychemedics Corporation Announces Reverse and Forward Stock SplitGlobeNewswireDALLAS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) (the "Company"), the world's leading provider of hair testing for drugs of abuse, today announced that, following the approval of the
1y agoPMDPsychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of StockholdersGlobeNewswireDALLAS, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), a global leader in hair testing, reminds its stockholders to vote ahead of the Company's upcoming annual meeting of stockholders
1y agoPMDPsychemedics Corporation Reports Third Quarter 2024 Financial ResultsGlobeNewswireDALLAS, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's leading provider of hair testing for drugs of abuse, today announced financial results for the third quarter ending September
2y agoPMDPsychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair TestingGlobeNewswireDALLAS, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), a global leader in hair testing for drugs of abuse, is excited to announce the release of its first-ever Education Insights Report. This
2y agoPMDPsychemedics Corporation Launches New Ketamine Hair Testing ServiceGlobeNewswireDALLAS, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), a global leader in hair testing, is proud to announce the launch of its new ketamine hair testing solution. This innovative testing
2y agoPMDPsychemedics Corporation Reports Second Quarter 2024 Financial ResultsGlobeNewswireDALLAS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's leading provider of hair testing for drugs of abuse, today announced financial results for the second quarter ending June 30,
2y agoPMDPsychemedics Corporation's Board of Directors Approves Plan to Terminate Registration of Its Common StockGlobeNewswireDALLAS, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) ("Psychemedics" or the "Company") today announced that a Transaction Committee (the "Transaction Committee") of the Board of Directors of
2y agoPMDPsychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair TestingGlobeNewswireDALLAS, June 21, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), a global leader in hair testing for drugs of abuse, proudly presents its inaugural Insights Report. This groundbreaking report offers a
2y agoPMDPsychemedics Corporation Reports First Quarter 2024 Financial ResultsGlobeNewswireDALLAS, May 14, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's leading provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31,
2y agoPMDPsychemedics Corporation Reports 2023 Financial ResultsGlobeNewswireDALLAS, March 28, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's leading provider of hair testing for drugs of abuse, announced today financial results for the year ended December 31, 2023.
2y agoPMDPsychemedics Recognized as a Top 10 Employee Health Testing Services ProviderGlobeNewswireDallas, TX, March 21, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), a global leader in drug testing using hair analysis, is proud to announce its recognition as one of the Top 10 Employee Health
2y agoPMDPsychemedics Corporation Announces Relocation of Headquarters to Dallas, TexasGlobeNewswireACTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair testing for drugs of abuse, proudly announces the relocation of its corporate headquarters from Acton, Massachusetts, to
2y agoNBSE PMDPsychemedics Corporation Appoints Daniella Mehalik as VP - FinanceGlobeNewswireACTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), a global leader in hair testing for substance abuse, proudly announces the appointment of Daniella Mehalik as its new Vice
3y agoPMDPsychemedics Corporation Reports Third Quarter 2023 Financial ResultsGlobeNewswireACTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), a leading provider of hair testing for drugs of abuse, today announced financial results for the third quarter ended September 30,
3y agoPMDUnveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug ScreenGlobeNewswireACTON, Mass., Oct. 27, 2023 (GLOBE NEWSWIRE) -- In an era marked by relentless change and the pressing need to adapt, Psychemedics, a pioneer in the drug screening industry, proudly announces the launch of a
3y agoPMDPsychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue OfficerGlobeNewswireACTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world's largest provider of hair testing for drugs of abuse, is pleased to announce the appointment of Shannon Shoemaker as its new Chief
3y agoPMDPsychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireACTON, Mass., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, announced the grant of inducement awards to its newly appointed
3y agoPMDPsychemedics Corporation Reports Second Quarter 2023 Financial ResultsGlobeNewswireACTON, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the second quarter ended
3y agoPMDPsychemedics Corporation Announces CEO Succession PlanGlobeNewswireBrian Hullinger Will Succeed Ray Kubacki as CEO Effective August 17, 2023 Mr. Hullinger Brings 30 Years of Leadership Experience and a Proven Track Record of Driving Growth ACTON, Mass., July 12, 2023 (GLOBE
3y agoPMDPsychemedics Corporation Reports First Quarter 2023 Financial Results and Declares Cash DividendGlobeNewswireACTON, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March
3y agoPMDPsychemedics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and Declares Quarterly Cash DividendGlobeNewswireACTON, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, announced today fourth quarter and full year financial results
4y agoPMDPsychemedics Corporation Reports Third Quarter 2022 Financial Results and Declares Quarterly Cash DividendGlobeNewswireACTON, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the third quarter ended
4y agoPMDPsychemedics Corporation Reports Second Quarter 2022 Financial Results and Declares Quarterly Cash DividendGlobeNewswireACTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the second quarter ended June 30, 2022. The Company also annou
4y agoALRM PMDPsychemedics Announces Two New Director Nominees for its 2022 Annual Meeting of Stockholders and Director Walter S. Tomenson, Jr.'s Retirement after More than 20 Years of Dedicated ServiceGlobeNewswireACTON, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) announced today that it will be nominating Peter H. Kamin and Darius G. Nevin to serve as new members of its Board of Directors at its upcoming Annual Meeting of St
4y agoPMDPsychemedics Corporation Reports First Quarter 2022 Financial Results and Declares Increased Cash DividendGlobeNewswireACTON, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2022, and the declaration of
4y agoPMDPsychemedics Corporation Reports Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewswireACTON, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, announced today fourth quarter and full year financial results for the period ended December 31, 20
4y agoPMDPsychemedics Corporation Welcomes Drew Reynolds to Its Board of Directors and Announces the Retirement of Harry Connick From His Director RoleGlobeNewswireACTON, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, is pleased to welcome Andrew "Drew" M. Reynolds to the Psychemedics Board of Directors effective Ap
4y agoPMDPsychemedics Corporation Declares Cash DividendGlobeNewswireACTON, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced that it has declared a cash dividend of $0.05 per share to be paid on December 30th,
5y agoPMDPsychemedics Corporation Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Quarter 2021GlobeNewswireACTON, Mass., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the third quarter ended September 30, 2021. The Company's r
5y agoPMDPsychemedics Corporation Reports Stronger Second Quarter 2021 Financial ResultsGlobeNewswireACTON, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the second quarter ended June 30, 2021. The Company's reven
5y agoPMDMontana Advisors Writes Open Letter to PsychemedicsBusiness WireMontana Advisors Calls for Self-Tender or Sale of Psychemedics Montana Advisors issues open letter to Psychemedics CEO (NASDAQ:PMD): Dear Kubacki: It was a pleasure speaking with you two months ago via Zoom. I appreciate the time you have give
5y agoPMDPsychemedics Corporation Reports First Quarter 2021 Financial ResultsGlobeNewswireACTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2021. The Company's reve
5y agoPMDPsychemedics Corporation Reports Fourth Quarter and Full Year 2020 Financial ResultsGlobeNewswireACTON, Mass., March 23, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs of abuse, today announced fourth quarter and full year...
5y agoPMDRobyn C. Davis Joins Psychemedics Board of DirectorsGlobeNewswireACTON, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Robyn C. Davis was unanimously elected to serve on the Board of Directors of Psychemedics...
5y agoPMDAndrew Limbek Joins Psychemedics Corporation as Vice President, ControllerGlobeNewswireACTON, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Andrew Limbek has joined the Company as Vice President, Controller. In this important role,...
5y agoPMDSarah Ashby Rejoins Psychemedics Corporation as Vice President, General CounselGlobeNewswireACTON, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Sarah Ashby has rejoined the company as Vice President, General Counsel. In this important...
6y agoPMDPsychemedics Announces Third Quarter ResultsGlobeNewswireACTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2020. The Company’s...
6y agoPMDPsychemedics Announces Second Quarter ResultsGlobeNewswireACTON, Mass., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced second quarter financial results for the period ended June 30, 2020. The Company’s revenue for...
6y agoPMDPsychemedics Announces First Quarter ResultsGlobeNewswireACTON, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2020. The Company’s revenue for...
6y agoPMDPsychemedics Announces a “Vaping Panel” to Detect and Deter the Use of Marijuana, CBD and NicotineGlobeNewswireACTON, Mass., May 05, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced a Vaping Panel to...
6y agoPMDPsychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDAGlobeNewswireACTON, Mass., April 29, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the first...
6y agoPMDPsychemedics Corporation to Webcast 2020 Annual Meeting of StockholdersGlobeNewswireACTON, Mass., April 28, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) will hold its Annual Meeting of Stockholders (“Annual Meeting”) on Thursday, May 14, 2020 at 2:00 p.m. ET. The...
6y agoPMDPsychemedics Corporation Announces 4th Quarter and Year-End ResultsGlobeNewswireACTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2019. The...
7y agoPMDPsychemedics Corporation Responds to Court DecisionGlobeNewswireACTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today issued a response to a Massachusetts Supreme Judicial Court ruling in the case of Boston Police Department...
7y agoPMDPsychemedics Announces Third Quarter Results and Declares 93rd Consecutive Quarterly DividendGlobeNewswireACTON, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2019. The Company also...